Differential requirement for nitric oxide in IGF-1-induced anti-apoptotic, anti-oxidant and anti-atherosclerotic effects

FEBS Letters

Volumn 585, Issue 19, 2011, Pages 3065-3072

  Sukhanov, Sergiy ^a   Higashi, Yusuke ^a   Shai, Shaw Yung ^a   Blackstock, Christopher ^a   Galvez, Sarah ^a   Vaughn, Charlotte ^a   Titterington, Jane ^b   Delafontaine, Patrick ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Atherosclerosis; Growth factors; Nitric oxide; Oxidative stress

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; LIPOPROTEIN LIPASE; N(G) NITRO DEXTRO ARGININE METHYL ESTER; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RISK; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME INHIBITION; HEART PROTECTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK REDUCTION; SMOOTH MUSCLE FIBER;

ANIMALS; ANTIOXIDANTS; AORTA; APOLIPOPROTEINS E; APOPTOSIS; ATHEROSCLEROSIS; CELL LINE; ENZYME INHIBITORS; GENE EXPRESSION PROFILING; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LIPOPROTEIN LIPASE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 80053223720     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2011.08.029     Document Type: Article

References (35)

1. D. Lloyd-Jones Heart disease and stroke statistics-2010 update: a report from the American Heart Association Circulation 121 2010 e46 e215
2. P. Libby Inflammation in atherosclerosis: transition from theory to practice Circ. J. 74 2010 213 220
3. P. Delafontaine, Y.H. Song, and Y. Li Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels Arterioscler. Thromb. Vasc. Biol. 24 2004 435 444 (Pubitemid 38326135)
4. T. Michel, and P.M. Vanhoutte Cellular signaling and NO production Pflugers Arch. 459 2010 807 816
5. C.B. Harrison Evidence that nitric oxide inhibits vascular inflammation and superoxide production via a p47phox-dependent mechanism in mice Clin. Exp. Pharmacol. Physiol. 37 2010 429 434
6. P.J. Kuhlencordt Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice Circulation 104 2001 448 454 (Pubitemid 32678276)
7. A. Blum, and H. Miller The effects of l-arginine on atherosclerosis and heart disease Int. J. Cardiovasc. Intervent. 2 1999 97 100 (Pubitemid 29317840)
8. W.K. Alderton, C.E. Cooper, and R.G. Knowles Nitric oxide synthases: structure, function and inhibition Biochem J. 357 2001 593 615 (Pubitemid 32735142)
9. S. Sukhanov IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice Arterioscler. Thromb. Vasc. Biol. 27 2007 2684 2690 (Pubitemid 350158923)
10. B. Paigen Quantitative assessment of atherosclerotic lesions in mice Atherosclerosis 68 1987 231 240 (Pubitemid 17159775)
11. L. Paulis Melatonin interactions with blood pressure and vascular function during l-NAME-induced hypertension J. Pineal Res. 48 2010 102 108
12. E.G. Shesely Elevated blood pressures in mice lacking endothelial nitric oxide synthase Proc. Natl. Acad. Sci. U S A 93 1996 13176 13181 (Pubitemid 26382789)
13. D. Tsikas Methods of quantitative analysis of the nitric oxide metabolites nitrite and nitrate in human biological fluids Free Radic. Res. 39 2005 797 815 (Pubitemid 40975073)
14. S.Y. Shai Smooth muscle cell-specific insulin-like growth factor-1 overexpression in Apoe-/- mice does not alter atherosclerotic plaque burden but increases features of plaque stability Arterioscler. Thromb. Vasc. Biol. 30 2010 1916 1924
15. J.R. Mead, and D.P. Ramji The pivotal role of lipoprotein lipase in atherosclerosis Cardiovasc. Res. 55 2002 261 269 (Pubitemid 34775276)
16. R. Goldman Control of lipoprotein lipase secretion by macrophages: effect of macrophage differentiation agents J. Leukoc. Biol. 47 1990 79 86 (Pubitemid 20015320)
17. J.C. Khoo, E.M. Mahoney, and J.L. Witztum Secretion of lipoprotein lipase by macrophages in culture J. Biol. Chem. 256 1981 7105 7108 (Pubitemid 11021797)
18. S.Y. Shai Low circulating insulin-like growth factor I increases atherosclerosis in ApoE-deficient mice Am. J. Physiol. Heart Circ. Physiol. 300 2011 H1898 H1906
19. T. Morishita Vasculoprotective roles of neuronal nitric oxide synthase FASEB J. 16 2002 1994 1996
20. P.A. Detmers Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient mice J. Immunol. 165 2000 3430 3435
21. J. Vasquez-Vivar Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors Proc. Natl. Acad. Sci. U S A 95 1998 9220 9225 (Pubitemid 28506212)
22. S. Kawashima, and M. Yokoyama Dysfunction of endothelial nitric oxide synthase and atherosclerosis Arterioscler. Thromb. Vasc. Biol. 24 2004 998 1005 (Pubitemid 38737823)
23. Y. Yatera Severe dyslipidaemia, atherosclerosis, and sudden cardiac death in mice lacking all NO synthases fed a high-fat diet Cardiovasc. Res. 87 2010 675 682
24. K. Kauser Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice Am. J. Physiol. Heart Circ. Physiol. 278 2000 H1679 H1685
25. J.H. von der Thusen IGF-1 has plaque-stabilizing effects in atherosclerosis by altering vascular smooth muscle cell phenotype Am. J. Pathol. 178 2011 924 934
26. T.R. Allen Evidence that insulin-like growth factor-1 requires protein kinase C-epsilon, PI3-kinase and mitogen-activated protein kinase pathways to protect human vascular smooth muscle cells from apoptosis Immunol. Cell Biol. 83 2005 651 667 (Pubitemid 43083098)
27. K.T. Iida Insulin inhibits apoptosis of macrophage cell line, THP-1 cells, via phosphatidylinositol-3-kinase-dependent pathway Arterioscler. Thromb. Vasc. Biol. 22 2002 380 386 (Pubitemid 34218742)
28. M.P. Morales IGF-1 regulates apoptosis of cardiac myocyte induced by osmotic-stress Biochem. Biophys. Res. Commun. 270 2000 1029 1035 (Pubitemid 30444826)
29. Y. Wang, S. Nagase, and A. Koyama Stimulatory effect of IGF-I and VEGF on eNOS message, protein expression, eNOS phosphorylation and nitric oxide production in rat glomeruli, and the involvement of PI3-K signaling pathway Nitric oxide 10 2004 25 35 (Pubitemid 38410892)
30. S. Repetto Insulin and IGF-I phosphorylate eNOS in HUVECs by a caveolin-1 dependent mechanism Biochem. Biophys. Res. Commun. 337 2005 849 852 (Pubitemid 41446991)
31. A. Lagumdzija Inhibited anabolic effect of insulin-like growth factor-I on stromal bone marrow cells in endothelial nitric oxide synthase-knockout mice Acta Physiol. Scand. 182 2004 29 35 (Pubitemid 39223063)
32. M.F. Walsh Insulin-like growth factor I diminishes in vivo and in vitro vascular contractility: role of vascular nitric oxide Endocrinology 137 1996 1798 1803 (Pubitemid 26133956)
33. V.B. Schini-Kerth Dual effects of insulin-like growth factor-I on the constitutive and inducible nitric oxide (NO) synthase-dependent formation of NO in vascular cells J. Endocrinol. Invest. 22 1999 82 88
34. K. Wilson Macrophage-specific expression of human lipoprotein lipase accelerates atherosclerosis in transgenic apolipoprotein e knockout mice but not in C57BL/6 mice Arterioscler. Thromb. Vasc. Biol. 21 2001 1809 1815 (Pubitemid 34219785)
35. O. Serri Enhanced lipoprotein lipase secretion and foam cell formation by macrophages of patients with growth hormone deficiency: possible contribution to increased risk of atherogenesis? J. Clin. Endocrinol. Metab. 89 2004 979 985 (Pubitemid 38269921)